These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

339 related articles for article (PubMed ID: 7761390)

  • 41. The apolipoprotein E allele epsilon 4 does not correlate with the number of senile plaques or neurofibrillary tangles in patients with Alzheimer's disease.
    Landén M; Thorsell A; Wallin A; Blennow K
    J Neurol Neurosurg Psychiatry; 1996 Oct; 61(4):352-6. PubMed ID: 8890772
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Truncated tau protein as a new marker for Alzheimer's disease.
    Novák M
    Acta Virol; 1994 Jun; 38(3):173-89. PubMed ID: 7817900
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Apolipoprotein E polymorphism and susceptibility to Alzheimer's disease.
    Kamboh MI
    Hum Biol; 1995 Apr; 67(2):195-215. PubMed ID: 7729825
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The Complex Role of Apolipoprotein E in Alzheimer's Disease: an Overview and Update.
    Mahoney-Sanchez L; Belaidi AA; Bush AI; Ayton S
    J Mol Neurosci; 2016 Nov; 60(3):325-335. PubMed ID: 27647307
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The effect of apolipoprotein E (ApoE) genotype on biomarkers of amyloidogenesis, tau pathology and neurodegeneration in Alzheimer's disease.
    Leoni V
    Clin Chem Lab Med; 2011 Mar; 49(3):375-83. PubMed ID: 21388338
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Progress toward identification of protease activity involved in proteolysis of apolipoprotein e in human brain.
    Marques MA; Owens PA; Crutcher KA
    J Mol Neurosci; 2004; 24(1):73-80. PubMed ID: 15314253
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Neurofibrillary tangle-predominant dementia: comparison with classical Alzheimer disease.
    Jellinger KA; Attems J
    Acta Neuropathol; 2007 Feb; 113(2):107-17. PubMed ID: 17089134
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Apolipoprotein E and Alzheimer disease: risk, mechanisms and therapy.
    Liu CC; Liu CC; Kanekiyo T; Xu H; Bu G
    Nat Rev Neurol; 2013 Feb; 9(2):106-18. PubMed ID: 23296339
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Neuropathology and apolipoprotein E profile of aged chimpanzees: implications for Alzheimer disease.
    Gearing M; Rebeck GW; Hyman BT; Tigges J; Mirra SS
    Proc Natl Acad Sci U S A; 1994 Sep; 91(20):9382-6. PubMed ID: 7937774
    [TBL] [Abstract][Full Text] [Related]  

  • 50. ApoE: crossroads between Alzheimer's disease and atherosclerosis.
    Stojakovic T; Scharnagl H; März W
    Semin Vasc Med; 2004 Aug; 4(3):279-85. PubMed ID: 15630629
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Isoform-specific proteolysis of apolipoprotein-E in the brain.
    Elliott DA; Tsoi K; Holinkova S; Chan SL; Kim WS; Halliday GM; Rye KA; Garner B
    Neurobiol Aging; 2011 Feb; 32(2):257-71. PubMed ID: 19278755
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Alzheimer's disease. The apolipoprotein E connection.
    Utermann G
    Curr Biol; 1994 Apr; 4(4):362-5. PubMed ID: 7922348
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Apolipoprotein E facilitates neuritic and cerebrovascular plaque formation in an Alzheimer's disease model.
    Holtzman DM; Fagan AM; Mackey B; Tenkova T; Sartorius L; Paul SM; Bales K; Ashe KH; Irizarry MC; Hyman BT
    Ann Neurol; 2000 Jun; 47(6):739-47. PubMed ID: 10852539
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Clinical and pathological correlates of apolipoprotein E epsilon 4 in Alzheimer's disease.
    Gomez-Isla T; West HL; Rebeck GW; Harr SD; Growdon JH; Locascio JJ; Perls TT; Lipsitz LA; Hyman BT
    Ann Neurol; 1996 Jan; 39(1):62-70. PubMed ID: 8572669
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Transgenic mice overexpressing amyloid beta protein are an incomplete model of Alzheimer disease.
    Schwab C; Hosokawa M; McGeer PL
    Exp Neurol; 2004 Jul; 188(1):52-64. PubMed ID: 15191802
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Apolipoprotein E in the genetics and epidemiology of Alzheimer's disease.
    Hardy J
    Am J Med Genet; 1995 Oct; 60(5):456-60. PubMed ID: 8546162
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Role of apoe/Abeta interactions in the pathogenesis of Alzheimer's disease and cerebral amyloid angiopathy.
    Holtzman DM
    J Mol Neurosci; 2001 Oct; 17(2):147-55. PubMed ID: 11816788
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Cerebral beta-amyloid deposition is augmented by the -491AA promoter polymorphism in non-demented elderly individuals bearing the apolipoprotein E epsilon4 allele.
    Pahnke J; Walker LC; Schroeder E; Vogelgesang S; Stausske D; Walther R; Warzok RW
    Acta Neuropathol; 2003 Jan; 105(1):25-9. PubMed ID: 12471457
    [TBL] [Abstract][Full Text] [Related]  

  • 59. ApoE, amyloid, and Alzheimer's disease.
    Hardy J
    Science; 1994 Jan; 263(5146):454-5. PubMed ID: 8290946
    [No Abstract]   [Full Text] [Related]  

  • 60. Amyloid-beta, tau alterations and mitochondrial dysfunction in Alzheimer disease: the chickens or the eggs?
    Smith MA; Drew KL; Nunomura A; Takeda A; Hirai K; Zhu X; Atwood CS; Raina AK; Rottkamp CA; Sayre LM; Friedland RP; Perry G
    Neurochem Int; 2002 May; 40(6):527-31. PubMed ID: 11850109
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.